アンジェスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2020/10/05 | 1,429 | 1,456 | 1,418 | 1,456 | +15 | +1% | 1,658,600 |
2020/10/02 | 1,448 | 1,479 | 1,434 | 1,441 | - | - | 1,793,000 |
2020/10/01 | 0 | 0 | 0 | 0 | - | - | 0 |
2020/09/30 | 1,476 | 1,486 | 1,446 | 1,448 | -29 | -2% | 1,559,800 |
2020/09/29 | 1,445 | 1,500 | 1,445 | 1,477 | +38 | +2.6% | 1,772,100 |
2020/09/28 | 1,458 | 1,468 | 1,433 | 1,439 | -24 | -1.6% | 1,777,400 |
2020/09/25 | 1,485 | 1,518 | 1,460 | 1,463 | -26 | -1.7% | 1,907,400 |
2020/09/24 | 1,513 | 1,530 | 1,479 | 1,489 | -46 | -3% | 2,426,600 |
2020/09/23 | 1,569 | 1,578 | 1,524 | 1,535 | -36 | -2.3% | 1,772,900 |
2020/09/18 | 1,617 | 1,617 | 1,556 | 1,571 | -31 | -1.9% | 3,480,700 |
2020/09/17 | 1,510 | 1,641 | 1,503 | 1,602 | +100 | +6.7% | 11,620,500 |
2020/09/16 | 1,493 | 1,515 | 1,490 | 1,502 | +12 | +0.8% | 1,432,500 |
2020/09/15 | 1,483 | 1,532 | 1,474 | 1,490 | +1 | +0.1% | 2,224,400 |
2020/09/14 | 1,519 | 1,522 | 1,481 | 1,489 | -25 | -1.7% | 1,856,700 |
2020/09/11 | 1,497 | 1,523 | 1,472 | 1,514 | +44 | +3% | 2,215,300 |
2020/09/10 | 1,522 | 1,525 | 1,470 | 1,470 | -52 | -3.4% | 2,692,300 |
2020/09/09 | 1,500 | 1,574 | 1,489 | 1,522 | +26 | +1.7% | 8,365,400 |
2020/09/08 | 1,423 | 1,499 | 1,416 | 1,496 | +71 | +5% | 2,940,300 |
2020/09/07 | 1,448 | 1,448 | 1,424 | 1,425 | -23 | -1.6% | 1,577,800 |
2020/09/04 | 1,432 | 1,480 | 1,430 | 1,448 | -19 | -1.3% | 2,125,600 |
2020/09/03 | 1,477 | 1,485 | 1,457 | 1,467 | -5 | -0.3% | 1,387,200 |
2020/09/02 | 1,480 | 1,504 | 1,450 | 1,472 | -15 | -1% | 2,998,900 |
2020/09/01 | 1,499 | 1,533 | 1,480 | 1,487 | -23 | -1.5% | 2,893,500 |
2020/08/31 | 1,447 | 1,510 | 1,423 | 1,510 | +89 | +6.3% | 3,734,300 |
2020/08/28 | 1,470 | 1,491 | 1,390 | 1,421 | -30 | -2.1% | 5,467,500 |
2020/08/27 | 1,492 | 1,508 | 1,451 | 1,451 | -66 | -4.4% | 3,106,200 |
2020/08/26 | 1,397 | 1,539 | 1,389 | 1,517 | +113 | +8% | 7,012,300 |
2020/08/25 | 1,450 | 1,460 | 1,400 | 1,404 | -86 | -5.8% | 6,024,600 |
2020/08/24 | 1,502 | 1,524 | 1,482 | 1,490 | -42 | -2.7% | 2,810,700 |
2020/08/21 | 1,574 | 1,581 | 1,517 | 1,532 | -38 | -2.4% | 3,585,800 |
2020/08/20 | 1,634 | 1,634 | 1,553 | 1,570 | -59 | -3.6% | 4,798,300 |
2020/08/19 | 1,661 | 1,667 | 1,616 | 1,629 | -17 | -1% | 4,394,400 |
2020/08/18 | 1,565 | 1,661 | 1,552 | 1,646 | +73 | +4.6% | 6,856,300 |
2020/08/17 | 1,580 | 1,583 | 1,536 | 1,573 | +2 | +0.1% | 2,774,300 |
2020/08/14 | 1,544 | 1,573 | 1,533 | 1,571 | +36 | +2.3% | 3,054,400 |
2020/08/13 | 1,541 | 1,569 | 1,525 | 1,535 | -5 | -0.3% | 3,579,100 |
2020/08/12 | 1,542 | 1,557 | 1,526 | 1,540 | -20 | -1.3% | 3,742,200 |
2020/08/11 | 1,600 | 1,622 | 1,541 | 1,560 | +50 | +3.3% | 8,441,600 |
2020/08/07 | 1,450 | 1,517 | 1,409 | 1,510 | +42 | +2.9% | 5,190,500 |
2020/08/06 | 1,540 | 1,558 | 1,452 | 1,468 | -90 | -5.8% | 5,922,700 |
2020/08/05 | 1,550 | 1,575 | 1,529 | 1,558 | +43 | +2.8% | 6,597,300 |
2020/08/04 | 1,563 | 1,595 | 1,486 | 1,515 | -23 | -1.5% | 15,098,900 |
2020/08/03 | 1,421 | 1,557 | 1,382 | 1,538 | +101 | +7% | 10,711,000 |
2020/07/31 | 1,387 | 1,519 | 1,371 | 1,437 | +57 | +4.1% | 13,085,100 |
2020/07/30 | 1,362 | 1,389 | 1,320 | 1,380 | +30 | +2.2% | 4,677,200 |
2020/07/29 | 1,351 | 1,383 | 1,307 | 1,350 | +26 | +2% | 4,855,100 |
2020/07/28 | 1,385 | 1,407 | 1,305 | 1,324 | -61 | -4.4% | 6,825,800 |
2020/07/27 | 1,382 | 1,434 | 1,370 | 1,385 | -27 | -1.9% | 5,420,700 |
2020/07/22 | 1,520 | 1,525 | 1,397 | 1,412 | -83 | -5.6% | 11,261,000 |
2020/07/21 | 1,329 | 1,496 | 1,326 | 1,495 | +46 | +3.2% | 16,296,800 |
1001~
1050
件表示中 / 3572件
類似銘柄と比較する
現在ご覧いただいている「アンジェス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
アンジェス | 4,900円 | +294.7% | - | 0.00% | - | 0.50倍 |
|
大阪大医学部、森下竜一教授創業の創薬ベンチャー。遺伝子治療薬を核に核酸医薬など開発多彩 |
Chordia | 23,600円 | - | - | 0.00% | - | 3.86倍 |
|
RNA制御ストレスを標的とする低分子抗がん薬を開発中。開発品・研究者は武田にルーツ |
オンコリス | 65,000円 | +58.7% | - | 0.00% | - | 10.49倍 |
|
腫瘍溶解ウイルス技術使うがん治療薬柱に感染症薬も開発。導出先が神経疾患薬を米国治験中 |
PRISMBio | 34,800円 | +167.9% | - | 0.00% | - | 5.41倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
メディシノバ | 25,200円 | - | - | - | - | - |
|
- |
市場注目の銘柄
チャート関連のコラム